SING LEE (08076) issues a profit warning, expecting a mid-term loss to widen to approximately 8.5 million yuan compared to the same period last year.
Xinyi Software (08076) announced that based on a preliminary assessment of the Group's unaudited consolidated management accounts for the six months ending June 30, 2026 (the "Reporting Period") and the information currently available, the Group expects to reduce its losses to approximately RMB 8.5 million, compared to approximately RMB 7.655 million in losses for the six months ending June 30, 2025 (the "2025 Period").
SING LEE (08076) announced that based on a preliminary assessment of the Group's unaudited consolidated management accounts for the six months ending June 30, 2026 (the Current Period) and the currently available information, the Group expects to reduce its loss to approximately RMB 8.5 million, compared to a loss of approximately RMB 7.655 million for the six months ended June 30, 2025 (the 2025 Period).
Based on the currently available information, the Board believes that the main reason for the increase in loss is due to a gross profit loss resulting from increased material and labor costs, rather than the gross profit recorded during the 2025 Period, along with the lack of reversal of impairment losses related to the recovery of long-outstanding accounts receivable, which was offset by increases in other income and losses.
Related Articles

Sinolink: The domestic AI sector is clearing more slowly than that overseas; a comprehensive improvement in non-AI sectors will still require patience.

JUFEEL (08611) released its interim results, reporting a loss attributable to shareholders of 5.763 million Malaysian Ringgit, an increase of 524.38% year-on-year.

MP CARDIOFLOW-B(02160): Shanghai Micro-Port MedBot and Shanghai Huiqing Orange Investment Management have entered into a leasing agreement.
Sinolink: The domestic AI sector is clearing more slowly than that overseas; a comprehensive improvement in non-AI sectors will still require patience.

JUFEEL (08611) released its interim results, reporting a loss attributable to shareholders of 5.763 million Malaysian Ringgit, an increase of 524.38% year-on-year.

MP CARDIOFLOW-B(02160): Shanghai Micro-Port MedBot and Shanghai Huiqing Orange Investment Management have entered into a leasing agreement.

RECOMMEND





